Balixafortide
Cat. No.:YN322137
| 产品名称: | Balixafortide | 
| CAS No.: | 1051366-32-5 | 
| Chemical Name: | |
| Synonyms: | POL6326 | 
| 分子量: | 1864.11 | 
| 分子式: | C84H118N24O21S2 | 
| SMILES: | CC1NNC(CC2=CN=C[NH]2)C(=O)NC(CC3=CC=C(O)C=C3)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)NC(CCC(N)=O)C(=O)NC(CC6=CC=C(O)C=C6)C(=O)NC7CSSCC(NC1=O)C(=O)NC(CO)C(=O)NC(C)C(=O)N8CCCC8C(=O)NC(CCN)C(=O)NC(CCCNC(N)=N)C(=O)C(=O)C(CC9=CC=C(O)C=C9)NC7=O | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Balixafortide (POL6326) 是一种有效的,选择性的,耐受性好的肽类CXCR4拮抗剂,其IC50小于 10 nM。Balixafortide 对CXCR4的选择性比包括CXCR7在内的许多受体高出 1000 倍。Balixafortide 以 IC50< 10 nM 阻断β-arrestin募集和钙通量。Balixafortide 还是一种有效的造血干细胞和祖细胞 (HSPC) 动员剂,并具有抗癌作用。 | 
| IC50和靶点: | [{name:"CXCR4:<10 nM (IC50)"}] | 
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |